DE60314902D1 - Fehlpaarungsendonukleasen und verwendungsverfahren - Google Patents
Fehlpaarungsendonukleasen und verwendungsverfahrenInfo
- Publication number
- DE60314902D1 DE60314902D1 DE60314902T DE60314902T DE60314902D1 DE 60314902 D1 DE60314902 D1 DE 60314902D1 DE 60314902 T DE60314902 T DE 60314902T DE 60314902 T DE60314902 T DE 60314902T DE 60314902 D1 DE60314902 D1 DE 60314902D1
- Authority
- DE
- Germany
- Prior art keywords
- heteroduplex
- complementarity
- polynucleotide
- mismatches
- increased
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
- C12N15/1027—Mutagenizing nucleic acids by DNA shuffling, e.g. RSR, STEP, RPR
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
- C12N15/8203—Virus mediated transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/00022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US98155 | 1987-09-18 | ||
US211079 | 1998-12-14 | ||
US35372202P | 2002-02-01 | 2002-02-01 | |
US353722P | 2002-02-01 | ||
US10/098,155 US20030157495A1 (en) | 2002-02-01 | 2002-03-14 | Nucleic acid molecules encoding CEL I endonuclease and methods of use thereof |
US10/211,079 US7078211B2 (en) | 2002-02-01 | 2002-08-01 | Nucleic acid molecules encoding endonucleases and methods of use thereof |
PCT/US2003/002958 WO2003066809A2 (en) | 2002-02-01 | 2003-01-31 | Mismatch endonucleases and methods of use |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60314902D1 true DE60314902D1 (de) | 2007-08-23 |
DE60314902T2 DE60314902T2 (de) | 2008-04-10 |
Family
ID=27739010
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60314902T Expired - Lifetime DE60314902T2 (de) | 2002-02-01 | 2003-01-31 | Fehlpaarungsendonukleasen und verwendungsverfahren |
Country Status (8)
Country | Link |
---|---|
US (4) | US7078211B2 (de) |
EP (1) | EP1565557B1 (de) |
JP (1) | JP4395632B2 (de) |
AT (1) | ATE366807T1 (de) |
AU (1) | AU2003207776B2 (de) |
CA (1) | CA2473187C (de) |
DE (1) | DE60314902T2 (de) |
WO (1) | WO2003066809A2 (de) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002079468A2 (en) * | 2001-02-02 | 2002-10-10 | Large Scale Biology Corporation | A method of increasing complementarity in a heteroduplex polynucleotide |
US20110111413A1 (en) * | 2001-02-02 | 2011-05-12 | Padgett Hal S | Method of optimizing codon usage through dna shuffling |
US7838219B2 (en) * | 2001-02-02 | 2010-11-23 | Novici Biotech Llc | Method of increasing complementarity in a heteroduplex |
US7078211B2 (en) * | 2002-02-01 | 2006-07-18 | Large Scale Biology Corporation | Nucleic acid molecules encoding endonucleases and methods of use thereof |
EP1574570A1 (de) * | 2004-03-12 | 2005-09-14 | Universität Regensburg | Verfahren zur Verringerung der Anzahl von fehlgepaarten Nukleotiden in doppelsträngigen Polynukleotiden |
ES2292270B1 (es) * | 2004-04-14 | 2009-02-16 | Oryzon Genomics, S.A. | Procedimiento para detectar selectivamente acidos nucleicos con estructuras atipicas convertibles en muescas. |
US20090053261A1 (en) * | 2005-09-08 | 2009-02-26 | Lindbo John A | Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications |
US20060029612A1 (en) * | 2004-04-15 | 2006-02-09 | Large Scale Biology Corporation | Prevention and treatment of recurrent respiratory papillomatosis |
US7729761B2 (en) * | 2004-07-14 | 2010-06-01 | Cardiac Pacemakers, Inc. | Method and apparatus for controlled gene or protein delivery |
CN102604914A (zh) * | 2004-07-30 | 2012-07-25 | 法国植物基因组研究计划-华莱 | 高敏感的内切核酸酶的生产方法、内切核酸酶的新制品及其用途 |
BRPI0616012A2 (pt) * | 2005-07-18 | 2011-05-31 | Protalix Ltd | administração via mucosa ou intestino de macromoléculas biologicamente ativas |
WO2007101028A2 (en) * | 2006-02-24 | 2007-09-07 | Transgenomic, Inc. | Method to produce enzymatically active recombinant endonucleases |
US7888475B2 (en) * | 2008-09-15 | 2011-02-15 | Padgett Hal S | Interferon alpha and interferon kappa fusion protein |
WO2011102802A1 (en) * | 2010-02-18 | 2011-08-25 | Agency For Science, Technology And Research | Method for reducing mismatches in double-stranded dna molecules |
CN103945931B (zh) | 2011-09-26 | 2017-03-22 | 基因技术股份公司 | 高效的小体积核酸合成 |
CA3156904A1 (en) * | 2012-02-01 | 2013-08-08 | Synthetic Genomics, Inc. | Materials and methods for the synthesis of error-minimized nucleic acid molecules |
US20130274129A1 (en) | 2012-04-04 | 2013-10-17 | Geneart Ag | Tal-effector assembly platform, customized services, kits and assays |
US10563240B2 (en) | 2013-03-14 | 2020-02-18 | Life Technologies Corporation | High efficiency, small volume nucleic acid synthesis |
US20150119260A1 (en) * | 2013-10-18 | 2015-04-30 | National Taiwan University | Circulating cancer biomarker and its use |
EP3169781B1 (de) | 2014-07-15 | 2020-04-08 | Life Technologies Corporation | Zusammensetzungen und verfahren zur nukleinsäureassemblierung |
LT3557262T (lt) | 2014-12-09 | 2022-11-10 | Life Technologies Corporation | Didelio efektyvumo nukleorūgščių sintezė mažame tūryje |
WO2017007925A1 (en) | 2015-07-07 | 2017-01-12 | Thermo Fisher Scientific Geneart Gmbh | Enzymatic synthesis of nucleic acid sequences |
EP3763818A1 (de) | 2015-10-06 | 2021-01-13 | Pierce Biotechnology, Inc. | Vorrichtungen und verfahren zur herstellung von proteinen |
JP2019502399A (ja) * | 2016-01-22 | 2019-01-31 | ビオーム バイオサイエンシズ プライベート リミティド | アクネ菌を検出し治療する方法及びそのキット |
WO2020001783A1 (en) | 2018-06-29 | 2020-01-02 | Thermo Fisher Scientific Geneart Gmbh | High throughput assembly of nucleic acid molecules |
GB201905303D0 (en) | 2019-04-15 | 2019-05-29 | Thermo Fisher Scient Geneart Gmbh | Multiplex assembly of nucleic acid molecules |
CN115244189A (zh) | 2020-03-06 | 2022-10-25 | 生命科技股份有限公司 | 高序列保真度核酸合成及组装 |
US11667968B2 (en) | 2021-05-27 | 2023-06-06 | New England Biolabs, Inc. | Fragmentation of DNA |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US48268A (en) * | 1865-06-20 | Improved process for preparing coffee | ||
US45175A (en) * | 1864-11-22 | Improved grinding-plate | ||
US17477A (en) * | 1857-06-09 | allerton | ||
CH0229046H1 (de) * | 1985-03-30 | 1998-07-15 | Stuart Alan Kauffman | Method for obtaining dna, rna, peptides, polypeptinique. des or proteins by means of a dna recombinant tech |
US4994368A (en) * | 1987-07-23 | 1991-02-19 | Syntex (U.S.A.) Inc. | Amplification method for polynucleotide assays |
US5556750A (en) * | 1989-05-12 | 1996-09-17 | Duke University | Methods and kits for fractionating a population of DNA molecules based on the presence or absence of a base-pair mismatch utilizing mismatch repair systems |
US5459039A (en) * | 1989-05-12 | 1995-10-17 | Duke University | Methods for mapping genetic mutations |
US5556747A (en) * | 1990-07-09 | 1996-09-17 | E. R. Squibb & Sons, Inc. | Method for site-directed mutagenesis |
DE4112440C1 (de) | 1991-04-16 | 1992-10-22 | Diagen Institut Fuer Molekularbiologische Diagnostik Gmbh, 4000 Duesseldorf, De | |
US5795747A (en) * | 1991-04-16 | 1998-08-18 | Evotec Biosystems Gmbh | Process for manufacturing new biopolymers |
AU3919293A (en) * | 1992-03-27 | 1993-11-08 | University Of Maryland At Baltimore | Detection of gene mutations with mismatch repair enzymes |
US6165793A (en) * | 1996-03-25 | 2000-12-26 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
JPH11506932A (ja) | 1995-06-07 | 1999-06-22 | トレビジェン インク. | 点変異の検出及びインビトロ突然変異誘発のための核酸修復酵素方法 |
US6057103A (en) * | 1995-07-18 | 2000-05-02 | Diversa Corporation | Screening for novel bioactivities |
JP2000501615A (ja) * | 1995-12-15 | 2000-02-15 | アマーシャム・ライフ・サイエンス・インコーポレーテッド | 酵素増幅中に生じる変異配列の検出および除去のためのミスマッチ修復系を用いる方法 |
WO1997037011A1 (en) | 1996-04-01 | 1997-10-09 | Setratech S.A.R.L. | Meiotic recombination in vivo of partially homologous dna sequences |
US5869245A (en) * | 1996-06-05 | 1999-02-09 | Fox Chase Cancer Center | Mismatch endonuclease and its use in identifying mutations in targeted polynucleotide strands |
AU721493B2 (en) | 1996-06-05 | 2000-07-06 | Fox Chase Cancer Center | Mismatch endonucleases and uses thereof in identifying mutations in targeted polynucleotide strands |
FR2772048B1 (fr) | 1997-12-04 | 2001-12-21 | Biomethodes | Procede de clonage par digestion multiple, vecteurs pour sa mise en oeuvre et ses applications |
JP3712255B2 (ja) | 1997-12-08 | 2005-11-02 | カリフォルニア・インスティチュート・オブ・テクノロジー | ポリヌクレオチドおよびポリペプチド配列を生成するための方法 |
US6846655B1 (en) * | 1998-06-29 | 2005-01-25 | Phylos, Inc. | Methods for generating highly diverse libraries |
FR2789696A1 (fr) | 1999-02-12 | 2000-08-18 | Biomethodes | Procede de mutagenese d'un fragment d'acide nucleique par clonage et polymerisation-ligation |
FR2793807B1 (fr) | 1999-05-20 | 2003-05-16 | Biomethodes | Methode d'insertion d'un fragment d'acide nucleique dans un vecteur, ses applications et les kits pour sa mise en oeuvre |
DE19953854C2 (de) | 1999-11-09 | 2002-01-17 | Max Planck Gesellschaft | Verfahren zur Herstellung von Biopolymeren mit veränderten Eigenschaften |
CA2400441C (en) | 2000-02-22 | 2013-08-27 | Fox Chase Cancer Center | Nucleic acid molecule encoding a mismatch endonuclease and methods of use thereof |
US6391557B1 (en) * | 2000-02-22 | 2002-05-21 | Fox Chase Cancer Center | Nucleic acid molecule encoding a mismatch endonuclease and methods of use thereof |
CA2405520A1 (en) * | 2000-05-23 | 2001-11-29 | California Institute Of Technology | Gene recombination and hybrid protein development |
FR2813314B1 (fr) | 2000-08-25 | 2004-05-07 | Biomethodes | Procede de mutagenese dirigee massive |
WO2002024953A1 (en) | 2000-09-21 | 2002-03-28 | Merck & Co., Inc. | Method for generating recombinant polynucleotides |
US6783941B2 (en) * | 2000-12-06 | 2004-08-31 | Novozymes A/S | Method for producing a polynucleotide library in vitro by mismatch repair of heteroduplexes |
WO2002079468A2 (en) | 2001-02-02 | 2002-10-10 | Large Scale Biology Corporation | A method of increasing complementarity in a heteroduplex polynucleotide |
US7078211B2 (en) * | 2002-02-01 | 2006-07-18 | Large Scale Biology Corporation | Nucleic acid molecules encoding endonucleases and methods of use thereof |
DE10248258A1 (de) | 2002-10-16 | 2004-05-06 | Biopsytec Analytik Gmbh | Mutierte Nukleinsäure einer Cel I-Endonuklease und Verfahren zur Herstellung des rekombinanten vollständigen Cel I-Proteins |
-
2002
- 2002-08-01 US US10/211,079 patent/US7078211B2/en not_active Expired - Lifetime
-
2003
- 2003-01-31 US US10/356,708 patent/US7056740B2/en not_active Expired - Lifetime
- 2003-01-31 AT AT03706015T patent/ATE366807T1/de not_active IP Right Cessation
- 2003-01-31 EP EP03706015A patent/EP1565557B1/de not_active Expired - Lifetime
- 2003-01-31 AU AU2003207776A patent/AU2003207776B2/en not_active Ceased
- 2003-01-31 JP JP2003566160A patent/JP4395632B2/ja not_active Expired - Fee Related
- 2003-01-31 WO PCT/US2003/002958 patent/WO2003066809A2/en active IP Right Grant
- 2003-01-31 CA CA2473187A patent/CA2473187C/en not_active Expired - Fee Related
- 2003-01-31 DE DE60314902T patent/DE60314902T2/de not_active Expired - Lifetime
-
2006
- 2006-05-03 US US11/417,448 patent/US7273739B2/en not_active Expired - Lifetime
-
2007
- 2007-09-24 US US11/860,465 patent/US20080145913A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ATE366807T1 (de) | 2007-08-15 |
US7056740B2 (en) | 2006-06-06 |
US20030148315A1 (en) | 2003-08-07 |
US7273739B2 (en) | 2007-09-25 |
WO2003066809A3 (en) | 2005-06-30 |
US20030157682A1 (en) | 2003-08-21 |
JP4395632B2 (ja) | 2010-01-13 |
US7078211B2 (en) | 2006-07-18 |
US20080145913A1 (en) | 2008-06-19 |
DE60314902T2 (de) | 2008-04-10 |
AU2003207776B2 (en) | 2008-12-11 |
WO2003066809A2 (en) | 2003-08-14 |
CA2473187C (en) | 2012-07-31 |
EP1565557B1 (de) | 2007-07-11 |
EP1565557A2 (de) | 2005-08-24 |
US20060194288A1 (en) | 2006-08-31 |
AU2003207776A1 (en) | 2003-09-02 |
JP2005529586A (ja) | 2005-10-06 |
EP1565557A4 (de) | 2005-11-30 |
CA2473187A1 (en) | 2003-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60314902D1 (de) | Fehlpaarungsendonukleasen und verwendungsverfahren | |
DE60234159D1 (de) | Methode zur erhöhung der komplementarität in einem heteroduplex-polynucleotid | |
WO2002026727A3 (en) | Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai | |
DK1929012T3 (da) | Fremgangsmåde til in vitro-rekombination | |
WO2001055470A3 (en) | Modified low temperature case hardening processes | |
PL414814A1 (pl) | Oligonukleotyd immunostymulujący oraz kompozycja zawierająca taki oligonukleotyd do zastosowania w stymulowaniu odpowiedzi immunologicznej | |
NO20054343L (no) | Behandling av immunologiske lidelser ved anvendelse av agonister av interleukin-21/interleukin-21 reseptor | |
WO2008097861A3 (en) | MODULATION OF NEUROGENESIS WITH BIGUANIDES AND GSK3-ß AGENTS | |
WO2005069893A3 (en) | Catalyst and method for its manufacture | |
NO20030548D0 (no) | Substratbehandling for rustfritt stål | |
WO2004101889A8 (en) | Use of hemicellulase composition in mechanical pulp production | |
MXPA04009380A (es) | Sistema y metodo para la construccion de un proceso de administracion de proyectos. | |
EP1752534A4 (de) | Hochgeschwindigkeits-pcr unter verwendung von hochgeschwindigkeits-dna-polymerase | |
AU8647101A (en) | Compounds having activity as inhibitors of cytochrome p450rai | |
DE60306662D1 (de) | Enzymatische pressfilzbehandlung | |
ATE239671T1 (de) | Verfahren zur herstellung von lithium-metall- oxiden | |
WO2003072743A3 (en) | Method for the recombination of genetic elements | |
WO2003012031A3 (en) | Antisense modulation of stearoyl-coa desaturase expression | |
WO2004010956A3 (en) | Antisense modulation of lar expression | |
EP1506216A4 (de) | Antisense-modulierung der kinesin-like-1-expression | |
WO2004011632A3 (en) | Oligodendrocyte production from multipotent neural stem cells | |
EP1495672A4 (de) | Funktionsfähige pflanze, promotor zur herstellung der funktionsfähigen pflanze, und verfahren zu ihrer verwendung | |
ATE309800T1 (de) | Verwendung einer kombinationszusammensetzung bestehend aus propionyl l-carnitin und weiteren wirkstoffen zur behandlung der erektilen dysfunktion | |
WO2005040370A3 (en) | Thermostable hydrolase | |
TW200407316A (en) | Crystal forms of quinoxaline-2-carboxylic acid [4-carbamoyl-1-(3-fluorobenzyl)-2,7-dihydroxy-7-methyl-octyl]-amide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |